teaser 1
Genetic variation drives individual treatment. We can now identify how a person will respond to a given treatment and tailor treatment to achieve the best possible outcome. Personalized Molecular Medicine is a proven proactive approach that provides critical information to empower you, in consultation with your physician, to make the best informed choices and to ensure the best possible outcome.

Molecular Diagnostics
Our diagnostic tests are used to identify biomarkers for leukemias, lymphomas, and other lymphoproliferative diseases. While most patients continue to be diagnosed and then lumped together for treatment as if they are all afflicted by the identical disease, prognostic, predictive and pharmacodynamic biomarker testing stratifies disease, permitting physicians to tailor treatment for each individual patient. This helps ensure optimal treatment and the best possible outcome.


The goal of Personalized Molecular Medicine is to ensure patients receive: "the right medication, in the right amount, in the right form, at the right time, for the right disease.


Everyone's Disease is Different

We now know that everyone’s disease is different; both because the molecular basis of disease varies from one individual to another, and because the genetics of each individual are different. Accordingly, individuals metabolize and utilize (or often are unable to utilize) drugs that are routinely prescribed for these various diseases. Learn which diagnostic tests are available for your disease.

Accurate Prognosis and Treatment

Personalized molecular medicine is gaining acceptance because it has become apparent that for many drugs and diseases some relatively simple and cost-effective tests can stratify patients according to their disease status and genetics so they can get maximal benefit from treatment options.

This is the promise and the realization of Personalized Molecular Medicine and there are clear examples of the resounding success of this new and exciting field.

Genomics & Proteomics

Personalized molecular medicine fulfills its promise when targeted therapies are coupled with molecular studies that confirm the efficacy of treatment – prior to the start of treatment. There are now a number of targeted small molecule candidates in late stages of regulatory approval that target specific gene targets. We test these specific gene targets to confirm mutation status prior to treatment.

 

sidebar-man-doctor.jpg
BIOMARKERS
Biomarkers are used to tailor treatments for the disease in an individual.

Which Biomarkers should you be tested for if you have been diagnosed with Leukemia, Lymphoma or a Lymphoproliferative disease?

Learn more